← Return to John Hopkins Webinar on transplant recipients and vaccines

Discussion
bosco17 (@bosco17)

John Hopkins Webinar on transplant recipients and vaccines

Transplants | Last Active: Jul 17 7:23pm | Replies (124)

Comment receiving replies
@estrada53

I believe the stats showed that 17% of those tested after dose 1 developed antibodies, not only 17 persons. It is a bit scary, as he said, yet others in the chat room shared their very high numbers of antibodies after dose 2.
I would have liked to have seen a breakdown by organ; also, each individual patient has a unique combination of meds. I'm wondering how deep the analysis will go with that. Will they create an algorithm to explore each med, each dosage, and each combination.
I appreciate their efforts as the clinical trials prior to vaccine distribution did not include us. This research is important.
Looking forward to seeing more. For now, even after bring vaccinated, I will continue with precautions.
Truth is, we are the ones who can teach others that none of us are going back to a past normal. The virus has changed us, just like our transplants have.

Jump to this post


Replies to "I believe the stats showed that 17% of those tested after dose 1 developed antibodies, not..."

Yes, you’re correct, it’s 17%. We’ll just have to keep following the results and be hopeful. I’m on both Tacrolimus and MFF, so both seem to present issues with developing resistance to the virus.